Loading…

CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.10303-10306
Main Authors:	McGuirk, Joseph P., Tam, Constantine S., Kröger, Nicolaus, Riedell, Peter A., Murthy, Hemant S., Ho, Phoebe Joy, Maakaron, Joseph E., Waller, Edmund K., Awan, Farrukh T., Shaughnessy, Paul J., Ghobadi, Armin, Bishop, Michael R., Alfonso-Pierola, Ana, Dickinson, Michael, Ramakrishnan Geethakumari, Praveen, Ross, Ainsley, Stevens, William, Xu, Huansheng, Ma, Anna, Cohen, Sarah Beaussant, Maziarz, Richard T., Bachier, Carlos
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!